Adherence Intervention for Breast Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This study aims to evaluate a multi-modal intervention designed to improve adherence to adjuvant endocrine therapy (AET) among patients with ER-positive breast cancer in Rwanda. The intervention includes educational, behavioral, and reminder components, and will be assessed for feasibility and impact on medication adherence.
Who Is on the Research Team?
Temidayo Fadelu, MD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a multi-modal medication adherence support package, including an educational video, a symptom monitoring card, and weekly text message reminders
Follow-up
Participants are monitored for adherence and quality of life using questionnaires and assessments
What Are the Treatments Tested in This Trial?
Interventions
- AET Pilot Intervention
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants randomized to the intervention arm will receive a light-touch, multi-modal medication adherence support package, including a one-time educational video, a symptom monitoring card, and weekly one-way text message reminders.
Participants will receive standard care.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.